The translocator protein gene is associated with endogenous pain modulation and the balance between glutamate and gamma-aminobutyric acid in fibromyalgia and healthy subjects [Elektronisk resurs] a multimodal neuroimaging study
-
Fanton, Silvia (författare)
-
Sandstrom, Angelica (författare)
-
Tour, Jeanette (författare)
-
Kadetoff, Diana (författare)
-
Schalling, Martin (författare)
-
Jensen, Karin B. (författare)
-
Sitnikov, Rouslan (författare)
-
Ellerbrock, Isabel (författare)
-
Kosek, Eva (författare)
-
Uppsala universitet Medicinska och farmaceutiska vetenskapsområdet (utgivare)
- Publicerad: Ovid Technologies (Wolters Kluwer Health), 2022
- Engelska.
-
Ingår i: Pain. - 0304-3959. ; 163:2, 274-286
-
Läs hela texten
-
Läs hela texten
-
Läs hela texten
Sammanfattning
Ämnesord
Stäng
- A cerebral upregulation of the translocator protein (TSPO), a biomarker of glial activation, has been reported in fibromyalgia subjects (FMS). The TSPO binding affinity is genetically regulated by the Ala147Thr polymorphism in the TSPO gene (rs6971) and allows for a subject classification into high affinity binders (HABs) and mixed/low affinity binders (MLABs). The aim of the present multimodal neuroimaging study was to examine the associations of the TSPO polymorphism with: (1) conditioned pain modulation, (2) expectancy-modulated pain processing assessed during functional magnetic resonance imaging, and (3) the concentration and balance of glutamate and gamma-aminobutyric acid in the rostral anterior cingulate cortex and thalamus using proton magnetic resonance spectroscopy in FMS (n = 83) and healthy controls (n = 43). The influence of TSPO on endogenous pain modulation presented in the form of TSPO HABs, as opposed to MLABs, displaying less efficient descending pain inhibition and expectancy-induced reduction of pain. Translocator protein HABs in both groups (FM and healthy controls) were found to have higher thalamic glutamate concentrations and exhibit a pattern of positive correlations between glutamate and gamma-aminobutyric acid in the rostral anterior cingulate cortex, not seen in MLABs. Altogether, our findings point to TSPO-related mechanisms being HAB-dependent, brain region-specific, and non-FM-specific, although in FMS the disadvantage of an aberrant pain regulation combined with an HAB genetic set-up might hamper pain modulation more strongly. Our results provide evidence for an important role of TSPO in pain regulation and brain metabolism, thereby supporting the ongoing drug development targeting TSPO-associated mechanisms for pain relief.
Ämnesord
- Medical and Health Sciences (hsv)
- Clinical Medicine (hsv)
- Neurology (hsv)
- Medicin och hälsovetenskap (hsv)
- Klinisk medicin (hsv)
- Neurologi (hsv)
Genre
- government publication (marcgt)
Indexterm och SAB-rubrik
- Fibromyalgia
- TSPO
- Genetic polymorphism
- Endogenous pain modulation
- MRS
- Glutamate
- GABA
- rACC
- Thalamus
- fMRI
Inställningar
Hjälp
Ingår i annan publikation. Gå till titeln
Pain